NO20073631L - Metasubstituerte tiazolidinoner, fremgangsmate for fremstilling og anvendelse av disse som legemiddel - Google Patents
Metasubstituerte tiazolidinoner, fremgangsmate for fremstilling og anvendelse av disse som legemiddelInfo
- Publication number
- NO20073631L NO20073631L NO20073631A NO20073631A NO20073631L NO 20073631 L NO20073631 L NO 20073631L NO 20073631 A NO20073631 A NO 20073631A NO 20073631 A NO20073631 A NO 20073631A NO 20073631 L NO20073631 L NO 20073631L
- Authority
- NO
- Norway
- Prior art keywords
- thiazolidinones
- preparation
- metasubstituted
- drugs
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004061503A DE102004061503A1 (de) | 2004-12-15 | 2004-12-15 | Metasubstituierte Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel |
US63777704P | 2004-12-22 | 2004-12-22 | |
PCT/EP2005/013418 WO2006063806A1 (de) | 2004-12-15 | 2005-12-12 | Metasubstituierte thiazolidinone, deren herstellung und verwendung als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20073631L true NO20073631L (no) | 2007-09-12 |
Family
ID=35895206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20073631A NO20073631L (no) | 2004-12-15 | 2007-07-13 | Metasubstituerte tiazolidinoner, fremgangsmate for fremstilling og anvendelse av disse som legemiddel |
Country Status (18)
Country | Link |
---|---|
US (2) | US20070015759A1 (zh) |
EP (1) | EP1824834A1 (zh) |
JP (1) | JP2008524139A (zh) |
KR (1) | KR20070092740A (zh) |
AR (1) | AR055698A1 (zh) |
AU (1) | AU2005315835A1 (zh) |
BR (1) | BRPI0519040A2 (zh) |
CA (1) | CA2590396A1 (zh) |
CR (1) | CR9183A (zh) |
GT (1) | GT200500366A (zh) |
IL (1) | IL183395A0 (zh) |
MX (1) | MX2007007245A (zh) |
NO (1) | NO20073631L (zh) |
PA (1) | PA8656501A1 (zh) |
PE (1) | PE20061157A1 (zh) |
TW (1) | TW200628458A (zh) |
UY (1) | UY29264A1 (zh) |
WO (1) | WO2006063806A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005005395A1 (de) * | 2005-02-03 | 2006-08-10 | Schering Aktiengesellschaft | Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel |
JP2009525046A (ja) * | 2006-01-31 | 2009-07-09 | エラン ファーマシューティカルズ,インコーポレイテッド | アルファ−シヌクレインキナーゼ |
JP2011515072A (ja) * | 2008-02-13 | 2011-05-19 | エラン ファーマ インターナショナル リミテッド | α−シヌクレインキナーゼ |
EP2141163A1 (de) * | 2008-07-02 | 2010-01-06 | Bayer Schering Pharma AG | Substituierte Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel |
JP5578705B2 (ja) * | 2010-03-29 | 2014-08-27 | 公益財団法人相模中央化学研究所 | (アリール)ジフルオロ酢酸エステル誘導体及びその製造方法 |
WO2014069434A1 (ja) * | 2012-10-30 | 2014-05-08 | カルナバイオサイエンス株式会社 | 新規チアゾリジノン誘導体 |
EP2976343A2 (en) * | 2013-03-20 | 2016-01-27 | Bayer Pharma Aktiengesellschaft | Substituted n-biphenyl-3-acetylamino-benzamides and n-[3-(acetylamino)phenyl]-biphenyl-carboxamides and their use as inhibitors of the wnt signalling pathway |
SG11201507615SA (en) * | 2013-03-20 | 2015-10-29 | Bayer Pharma AG | 3-acetylamino-1-(phenyl-heteroaryl-aminocarbonyl or phenyl-heteroaryl-carbonylamino)benzene derivatives for the treatment of hyperproliferative disorders |
WO2015116696A1 (en) | 2014-01-28 | 2015-08-06 | Massachusetts Institute Of Technology | Combination therapies and methods of use thereof for treating cancer |
MA39533B1 (fr) * | 2014-06-16 | 2018-11-30 | Univ Lille Ii Droit & Sante | Composés, composition pharmaceutique et leur utilisation dans le traitement de maladies neurodégénératives |
US20230263783A1 (en) | 2022-02-18 | 2023-08-24 | Massachusetts Institute Of Technology | Cancer treatment by combined inhibition of polo-like kinase and microtubule polymerization |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1649853A (zh) * | 2002-05-03 | 2005-08-03 | 舍林股份公司 | 噻唑烷酮类化合物、其制备方法以及作为药物的应用 |
DE10351744A1 (de) * | 2003-10-31 | 2005-06-16 | Schering Ag | Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel |
-
2005
- 2005-12-12 KR KR1020077016301A patent/KR20070092740A/ko not_active Application Discontinuation
- 2005-12-12 CA CA002590396A patent/CA2590396A1/en not_active Abandoned
- 2005-12-12 WO PCT/EP2005/013418 patent/WO2006063806A1/de active Application Filing
- 2005-12-12 MX MX2007007245A patent/MX2007007245A/es not_active Application Discontinuation
- 2005-12-12 JP JP2007545935A patent/JP2008524139A/ja active Pending
- 2005-12-12 EP EP05813723A patent/EP1824834A1/de not_active Withdrawn
- 2005-12-12 AU AU2005315835A patent/AU2005315835A1/en not_active Abandoned
- 2005-12-12 BR BRPI0519040-1A patent/BRPI0519040A2/pt not_active Application Discontinuation
- 2005-12-13 GT GT200500366A patent/GT200500366A/es unknown
- 2005-12-14 PE PE2005001453A patent/PE20061157A1/es not_active Application Discontinuation
- 2005-12-14 AR ARP050105228A patent/AR055698A1/es not_active Application Discontinuation
- 2005-12-14 US US11/302,537 patent/US20070015759A1/en not_active Abandoned
- 2005-12-15 PA PA20058656501A patent/PA8656501A1/es unknown
- 2005-12-15 TW TW094144578A patent/TW200628458A/zh unknown
- 2005-12-20 UY UY29264A patent/UY29264A1/es not_active Application Discontinuation
-
2007
- 2007-05-24 IL IL183395A patent/IL183395A0/en unknown
- 2007-06-13 CR CR9183A patent/CR9183A/es not_active Application Discontinuation
- 2007-07-13 NO NO20073631A patent/NO20073631L/no not_active Application Discontinuation
-
2009
- 2009-04-29 US US12/432,213 patent/US20100048891A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2005315835A1 (en) | 2006-06-22 |
CR9183A (es) | 2008-01-21 |
PE20061157A1 (es) | 2006-11-16 |
AR055698A1 (es) | 2007-09-05 |
EP1824834A1 (de) | 2007-08-29 |
TW200628458A (en) | 2006-08-16 |
UY29264A1 (es) | 2006-06-30 |
GT200500366A (es) | 2006-12-04 |
US20070015759A1 (en) | 2007-01-18 |
US20100048891A1 (en) | 2010-02-25 |
PA8656501A1 (es) | 2006-09-08 |
MX2007007245A (es) | 2008-02-25 |
CA2590396A1 (en) | 2006-06-22 |
JP2008524139A (ja) | 2008-07-10 |
BRPI0519040A2 (pt) | 2009-01-13 |
WO2006063806A1 (de) | 2006-06-22 |
IL183395A0 (en) | 2007-09-20 |
KR20070092740A (ko) | 2007-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20073631L (no) | Metasubstituerte tiazolidinoner, fremgangsmate for fremstilling og anvendelse av disse som legemiddel | |
NO20090628L (no) | Pyridizinon derivativater | |
NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
SE0402735D0 (sv) | Novel compounds | |
NO20081729L (no) | Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer | |
SG170101A1 (en) | 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. | |
NO20071915L (no) | Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer | |
SE0301700D0 (sv) | Novel compounds | |
TW200615266A (en) | Organic compounds | |
NO20073859L (no) | Pyrrolopyrazoler, potente kinaseinhibitorer | |
NO20090295L (no) | Substituerte heteroarylderivater | |
GEP20084452B (en) | Sulfonamide derivatives for the treatment of diseases | |
LTC1781298I2 (lt) | Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui | |
NO20064041L (no) | Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter | |
NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
NO20071074L (no) | Substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer | |
NO20081844L (no) | Terapeutiske forbindelser | |
NO20062453L (no) | Tiozolidinoner, fremstilling og anvendelse derav som legemidler | |
EA200801997A1 (ru) | Новые соединения | |
NO20081942L (no) | Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser | |
NO20083708L (no) | 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer | |
NO20076145L (no) | Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav | |
TW200639155A (en) | Thiazolidinones, their production and use as pharmaceutical agents | |
NO20071805L (no) | Alkylidentetrahydronaftalenderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |